Botulinum toxin typeA for the treatment of lower urinary tract disorders

Teruhiko Yokoyama, Michael B. Chancellor, Keiji Oguma, Yumiko Yamamoto, Tomonori Suzuki, Hiromi Kumon, Atsushi Nagai

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Many papers report the clinical success of botulinum toxinA as a method of management of various bladder dysfunctions. The rationale was that botulinum toxinA was able to block the presynaptic release of acetylcholine from the parasympathetic efferent nerve. The efficacy might result not only from an inhibitory effect on detrusor muscle, but also some effects might be mediated by altering the afferent nerve input. This systematic literature review discusses the efficacy and safety of botulinum toxinA therapy for idiopathic detrusor overactivity, neurogenic detrusor overactivity, interstitial cystitis/painful bladder syndrome and benign prostatic hyperplasia. The information was gathered from a PubMed literature research for abstracts from recent urological meetings. Injection of botulinum toxinA appears to have a positive therapeutic effect in multiple urological conditions, such as refractory idiopathic detrusor overactivity, neurogenic detrusor overactivity, interstitial cystitis/painful bladder syndrome and benign prostatic hyperplasia. Because the United States Food and Drug Administration has approved botulinum toxinA (Botox) for injection for the treatment of urinary incontinence as a result of neurogenic detrusor overactivity (e.g. spinal cord injury, multiple sclerosis) in adults who have an inadequate response to or are intolerant of an ant cholinergic medication, the use of botulinum toxinA will spread and be a more familiar therapy in the urological arena. However, further robust evidence should be awaited. We will discuss the current use of this agent within the urological field.

Original languageEnglish
Pages (from-to)202-215
Number of pages14
JournalInternational Journal of Urology
Volume19
Issue number3
DOIs
Publication statusPublished - Mar 1 2012

Keywords

  • Bladder
  • Botulinum toxin typeA
  • Detrusor overactivity
  • Idiopathic
  • Neurogenic
  • Prostate
  • Urethra

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Botulinum toxin typeA for the treatment of lower urinary tract disorders'. Together they form a unique fingerprint.

  • Cite this